Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The National Tissue Engineering Center of China (NTEC) is a premier institution dedicated to the research, development, and commercialization of regenerative medicine technologies. Founded by the renowned scientist Professor Yilin Cao, the center focuses on the creation of functional tissue substitutes, including skin, cartilage, bone, and tendons, using advanced tissue engineering principles. NTEC operates a sophisticated platform that combines seed cells, biocompatible scaffolds, and growth factors to address complex clinical needs in plastic surgery and orthopedics. Its commercial arm, Shanghai Tissue Engineering Co., Ltd., facilitates the translation of laboratory breakthroughs into clinical products, such as tissue-engineered skin for chronic wound healing. The center is recognized globally for its pioneering work in ear reconstruction using patient-derived cells. By integrating academic excellence with industrial manufacturing, NTEC remains at the forefront of the biotech landscape in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on National Tissue Engineering Center of China.